Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROFECOXIB vs ROSIGLITAZONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROFECOXIB vs ROSIGLITAZONE: Safety Overview

Metric ROFECOXIB ROSIGLITAZONE
Total FAERS Reports 1,238 45,976
Deaths Reported 56 4,661
Death Rate 4.5% 10.1%
Hospitalizations 176 23,675
Average Patient Age 63.1 yrs 60.2 yrs
% Female Patients 77.9% 42.8%
FDA Approval Date Feb 25, 2000 Jan 25, 2013
Marketing Status Discontinued Discontinued